[
  {
    "ts": null,
    "headline": "Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon",
    "summary": "Aurinia Pharmaceuticals Inc. had a solid Q3 and announced cost cuts, sparking rumors of potential acquisition and continued profitability. Read more here.",
    "url": "https://finnhub.io/api/news?id=016f0b8169860bf8a4ce466f1bbcc11b423938da5516b43d04ad6b265003f853",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731068131,
      "headline": "Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon",
      "id": 131223615,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155151969/image_155151969.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Aurinia Pharmaceuticals Inc. had a solid Q3 and announced cost cuts, sparking rumors of potential acquisition and continued profitability. Read more here.",
      "url": "https://finnhub.io/api/news?id=016f0b8169860bf8a4ce466f1bbcc11b423938da5516b43d04ad6b265003f853"
    }
  }
]